Many stroke survivors live with persistent motor, cognitive, aphasic and functional deficits despite standard
rehabilitation. Repetitive Transcranial Magnetic Stimulation (rTMS) offers a non-invasive, evidence-based approach to enhancing neuroplasticity and improving outcomes as part of an integrated care plan.
rTMS uses magnetic pulses to modulate cortical excitability and promote neuroplasticity in targeted brain regions. By stimulating the motor cortex or inhibiting maladaptive contralesional activity, rTMS supports cortical reorganization crucial for recovery.
Motor Recovery: Meta-analyses show rTMS improves upper limb and motor function, particularly within six month post-stroke.
Aphasia: Low-frequency rTMS over right Broca’s homologue improves naming and fluency.
Dysphagia & Cognition: Studies show benefits in swallowing, attention, and working memory.
Post-Stroke Depression: High-frequency left DLPFC stimulation improves mood and motivation for rehabilitation.
rTMS modulates interhemispheric balance, enhancing excitability in the lesioned hemisphere while dampening
overactive contralesional networks. This neuromodulation promotes reorganization and synaptic plasticity that underpin motor and cognitive recovery.
• Ideal for patients with persistent deficits despite therapy
• Most effective when combined with PT/OT/SLP
• Typically 20–30 sessions; safe and well-tolerated
rTMS is appropriate for patients with:
• Motor weakness or spasticity
• Post-stroke aphasia
• Cognitive deficits
• Post-stroke depression or pain syndromes
Our clinic provides comprehensive evaluation, protocol planning, and communication with referring neurologists and rehabilitation specialists.
• Neuromodulation expertise with advanced TMS protocols
• Multidisciplinary approach integrating psychiatry, neurology, and rehabilitation
• Objective outcome tracking (Fugl-Meyer, WAB, etc.)
• Streamlined referral and progress updates to referring clinicians
Chronic pain persists for millions of patients despite multimodal interventions. Repetitive Transcranial Magnetic
Stimulation (rTMS) is a non-invasive, evidence-based option targeting cortical pain circuits, offering a novel mechanism to reduce central sensitization and enhance quality of life.
rTMS delivers focused magnetic pulses that modulate cortical excitability and reorganize pain-processing networks. Stimulation of the motor cortex (M1) or prefrontal cortex has been shown to attenuate chronic pain perception by influencing descending inhibitory pathways.
Neuropathic Pain: Multiple meta-analyses demonstrate significant pain reduction following high-frequency (10–20 Hz) rTMS to M1. Benefits observed in post-stroke pain, diabetic neuropathy, and spinal cord injury-related pain.
Fibromyalgia: Trials show moderate improvement in pain and fatigue when rTMS targets the left dorsolateral prefrontal cortex.
Chronic Low Back Pain: Early evidence suggests improvements in both pain intensity and function.
Post-Stroke Central Pain: Controlled studies report reductions in neuropathic pain scores and increased cortical inhibition post-rTMS.
Ideal candidates include patients with:
• Chronic neuropathic pain (post-stroke, spinal cord injury, diabetic)
• Fibromyalgia or centralized pain syndromes
• Refractory pain despite medications, injections, or therapy
• Co-existing depression or anxiety (dual benefit via DLPFC stimulation)
rTMS complements interventional and medical pain management. We work alongside pain specialists to identify candidates, design protocols, and track functional outcomes using standardized measures (VAS, BPI, SF-36).
• Specialized expertise in neuromodulation and TMS protocols
• Evidence-based, individualized treatment plans
• Coordination with referring physicians
• Integration with physical therapy, behavioral health, and pharmacologic management
Many stroke survivors live with persistent motor, cognitive, aphasic and functional deficits despite standard
rehabilitation. Repetitive Transcranial Magnetic Stimulation (rTMS) offers a non-invasive, evidence-based approach to enhancing neuroplasticity and improving outcomes as part of an integrated care plan.
rTMS uses magnetic pulses to modulate cortical excitability and promote neuroplasticity in targeted brain regions. By stimulating the motor cortex or inhibiting maladaptive contralesional activity, rTMS supports cortical reorganization crucial for recovery.
Motor Recovery: Meta-analyses show rTMS improves upper limb and motor function, particularly within six month post-stroke.
Aphasia: Low-frequency rTMS over right Broca’s homologue improves naming and fluency.
Dysphagia & Cognition: Studies show benefits in swallowing, attention, and working memory.
Post-Stroke Depression: High-frequency left DLPFC stimulation improves mood and motivation for rehabilitation.
rTMS modulates interhemispheric balance, enhancing excitability in the lesioned hemisphere while dampening
overactive contralesional networks. This neuromodulation promotes reorganization and synaptic plasticity that underpin motor and cognitive recovery.
• Ideal for patients with persistent deficits despite therapy
• Most effective when combined with PT/OT/SLP
• Typically 20–30 sessions; safe and well-tolerated
rTMS is appropriate for patients with:
• Motor weakness or spasticity
• Post-stroke aphasia
• Cognitive deficits
• Post-stroke depression or pain syndromes
Our clinic provides comprehensive evaluation, protocol planning, and communication with referring neurologists and rehabilitation specialists.
• Neuromodulation expertise with advanced TMS protocols
• Multidisciplinary approach integrating psychiatry, neurology, and rehabilitation
• Objective outcome tracking (Fugl-Meyer, WAB, etc.)
• Streamlined referral and progress updates to referring clinicians
Chronic pain persists for millions of patients despite multimodal interventions. Repetitive Transcranial Magnetic
Stimulation (rTMS) is a non-invasive, evidence-based option targeting cortical pain circuits, offering a novel mechanism to reduce central sensitization and enhance quality of life.
rTMS delivers focused magnetic pulses that modulate cortical excitability and reorganize pain-processing networks. Stimulation of the motor cortex (M1) or prefrontal cortex has been shown to attenuate chronic pain perception by influencing descending inhibitory pathways.
Neuropathic Pain: Multiple meta-analyses demonstrate significant pain reduction following high-frequency (10–20 Hz) rTMS to M1. Benefits observed in post-stroke pain, diabetic neuropathy, and spinal cord injury-related pain.
Fibromyalgia: Trials show moderate improvement in pain and fatigue when rTMS targets the left dorsolateral prefrontal cortex.
Chronic Low Back Pain: Early evidence suggests improvements in both pain intensity and function.
Post-Stroke Central Pain: Controlled studies report reductions in neuropathic pain scores and increased cortical inhibition post-rTMS.
Ideal candidates include patients with:
• Chronic neuropathic pain (post-stroke, spinal cord injury, diabetic)
• Fibromyalgia or centralized pain syndromes
• Refractory pain despite medications, injections, or therapy
• Co-existing depression or anxiety (dual benefit via DLPFC stimulation)
rTMS complements interventional and medical pain management. We work alongside pain specialists to identify candidates, design protocols, and track functional outcomes using standardized measures (VAS, BPI, SF-36).
• Specialized expertise in neuromodulation and TMS protocols
• Evidence-based, individualized treatment plans
• Coordination with referring physicians
• Integration with physical therapy, behavioral health, and pharmacologic management
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more antidepressants haven’t worked.